首页|血液灌流联合血液透析治疗尿毒症的临床效果观察

血液灌流联合血液透析治疗尿毒症的临床效果观察

扫码查看
目的 本文探讨血液灌流联合血液透析治疗尿毒症的临床效果。方法 选取2022年4月—2023年4月本院收治的284例尿毒症患者为研究对象,将患者按入院顺序分成对照组和观察组,每组142例。对照组接受血液透析治疗,观察组患者在此基础上联合血液灌流,展开疗效分析与比对。结果 治疗前,两组患者肾功能差异无统计学意义(P>0。05);治疗后,观察组患者的血肌酐、尿素氮、β2-微球蛋白各项指标均优于对照组,组间差异有统计学意义(P<0。05)。治疗后,观察组治疗总有效率显著高于对照组,组间差异有统计学意义(P<0。05)。观察组并发症发生率低于对照组,两组数据差异有统计学意义(P<0。05)。结论 针对尿毒症患者的治疗,采用血液灌流联合血液透析的治疗方案,能够显著改善患者的病情,有效促进各项生理指标的优化,进而提升患者的生活质量。同时,该治疗方案对提升患者的肾功能亦具有积极作用。因此,在临床实践中,可广泛推广和应用。
Clinical Effect Observation of Blood Perfusion Combined with Hemodialysis in Treatment of Uremia
Objective To explore clinical effect of blood perfusion combined with hemodialysis in treatment of uremia.Methods The paper chose 284 uremic patients admitted to our hospital from April 2022 to April 2023 for study,and divided them into control and observation group based on admission order.Control group was treated with hemodialysis treatment,while observation group with combined blood perfusion on the basis.Curative effect was analyzed and comparied.Results There was no significant difference in renal function between two groups before treatment,with P>0.05.After treatment,indicators of blood creatinine,urea nitrogen,and β2-microglobulin were better than control group,there was significant difference in liver function indicators between two groups(P<0.05).Treatment effect comparison showed,total effective rate of observation group was 98.6%,significantly higher than 87.3%of control group,(P<0.05).Incidence of complications in observation group was 2.8%,significantly lower than 10.6%of control group.There was statistical significance between two groups(P<0.05).Conclusion Blood perfusion combined with hemodialysis treatment can effectively improve condition,promote improvement of various indicators,improve life quality,and renal function of uremia patients,which can be widely applied and promoted in clinical practice.

Blood perfusionHemodialysisUremiaClinical effect

段锡娟

展开 >

庆阳市第二人民医院 肾病科,甘肃 庆阳 745000

血液灌流 血液透析 尿毒症 临床效果

2024

智慧健康

智慧健康

ISSN:
年,卷(期):2024.10(10)